GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001065.PFD) » Definitions » Additional Paid-In Capital

JW Pharmaceutical (XKRX:001065.PFD) Additional Paid-In Capital : ₩101,615.98 Mil(As of Mar. 2025)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Additional Paid-In Capital?


JW Pharmaceutical's quarterly additional paid-in capital stayed the same from Sep. 2024 (₩101,615.98 Mil) to Dec. 2024 (₩101,615.98 Mil) and stayed the same from Dec. 2024 (₩101,615.98 Mil) to Mar. 2025 (₩101,615.98 Mil).

JW Pharmaceutical's annual additional paid-in capital declined from Dec. 2022 (₩104,357.96 Mil) to Dec. 2023 (₩102,769.93 Mil) and declined from Dec. 2023 (₩102,769.93 Mil) to Dec. 2024 (₩101,615.98 Mil).


JW Pharmaceutical Additional Paid-In Capital Historical Data

The historical data trend for JW Pharmaceutical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Additional Paid-In Capital Chart

JW Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97,817.18 96,629.09 104,357.96 102,769.93 101,615.98

JW Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101,615.98 101,615.98 101,615.98 101,615.98 101,615.98

JW Pharmaceutical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

JW Pharmaceutical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines